Partnering with the private laboratories to strengthen TB diagnostics in Nigeria
Ali, T.; Singh, U.; Ohikhuai, C.; Panwal, T.; Adetiba, T.; Agbaje, A.; Olusola Faleye, B.; Shyam Klinton, J.; Oga-Omenka, C.; Tseja-Akinrin, A.; Heitkamp, P.
Journal of Clinical Tuberculosis and other Mycobacterial Diseases 31: 100369
2023
ISSN/ISBN: 2405-5794 PMID: 37122613 Document Number: 237315
Despite being curable and preventable, tuberculosis (TB) affected 10 million people worldwide in 2020. In the seven highest TB burden countries, private providers account for more than two-thirds of initial care seeking. Closing gaps and finding the "missing people" with TB requires engagement of the private sector for better diagnostics and treatment. This review explores the efforts of a public-private partnership to enhance TB diagnostics in Nigeria, covering logistics and the distribution of GeneXpert machines and other diagnostic tools. Over three years, the Nigerian "hub and spoke" model led to a 28-fold increase in referrals of people with presumed TB in private diagnostic facilities. Various stakeholders' perspectives are also included, providing insight into opportunities and challenges of working with the private sector in this effort. As countries tackle the setbacks brought by COVID-19 and move towards reaching the End TB targets, partnerships such as these can strengthen the foundations of health systems.